GLUE · Monte Rosa Therapeutics
The AI's read
The share move alone says nothing about Monte Rosa's medicines, sales, or finances. The story reports no company development, so its outlook remains unchanged.
Monte Rosa Therapeutics shares rose 9.7% after hours. The story gives no company update, so this move alone does not change its outlook.
The share move alone says nothing about Monte Rosa's medicines, sales, or finances. The story reports no company development, so its outlook remains unchanged.
Filana Therapeutics shares rose 8.2% after hours. The story gives no company update, so this move alone does not change its outlook.
Tessera Defense shares rose 7.3% after hours. The story gives no company update, so this move alone does not change its outlook.
Kala Bio shares rose 7.0% after hours. The story gives no company update, so this move alone does not change its outlook.
Adagio Medical Holdings shares rose 6.5% after hours. The story gives no company update, so this move alone does not change its outlook.
Connect Biopharma shares rose 6.4% after hours. The story gives no company update, so this move alone does not change its outlook.
Follow Monte Rosa Therapeutics (GLUE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for GLUE